These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21922503)

  • 21. Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.
    Aronson MR; Simonson AW; Orchard LM; Llinás M; Medina SH
    Acta Biomater; 2018 Oct; 80():269-277. PubMed ID: 30240951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of a new short anticancer peptide with good potential for cancer treatment.
    Wu X; Tian Y; Ran K; Yao J; Wang Y; Ouyang X; Mao W; Zhang J; Li B; Yang P; Ba Z; Liu H; Gou S; Zhong C; Zhang Y; Ni J
    Eur J Med Chem; 2024 Jul; 273():116519. PubMed ID: 38795519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of charge, hydrophobicity, and structure with antimicrobial activity of S1 and MIRIAM peptides.
    Leptihn S; Har JY; Wohland T; Ding JL
    Biochemistry; 2010 Nov; 49(43):9161-70. PubMed ID: 20873868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).
    Chiangjong W; Chutipongtanate S; Hongeng S
    Int J Oncol; 2020 Sep; 57(3):678-696. PubMed ID: 32705178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of lipids in the interaction of antimicrobial peptides with membranes.
    Teixeira V; Feio MJ; Bastos M
    Prog Lipid Res; 2012 Apr; 51(2):149-77. PubMed ID: 22245454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational Design of Biologically Active Anticancer Peptides and Their Interactions with Heterogeneous POPC/POPS Lipid Membranes.
    Singh M; Kumar V; Sikka K; Thakur R; Harioudh MK; Mishra DP; Ghosh JK; Siddiqi MI
    J Chem Inf Model; 2020 Jan; 60(1):332-341. PubMed ID: 31880450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing the assembly behaviors of human amylin: a perspective derived from C-terminal variants.
    Chen MS; Zhao DS; Yu YP; Li WW; Chen YX; Zhao YF; Li YM
    Chem Commun (Camb); 2013 Mar; 49(18):1799-801. PubMed ID: 23146899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
    Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of acidic residues and amphipathicity on the lytic activities of mastoparan peptides studied by fluorescence and CD spectroscopy.
    Leite NB; da Costa LC; Dos Santos Alvares D; Dos Santos Cabrera MP; de Souza BM; Palma MS; Ruggiero Neto J
    Amino Acids; 2011 Jan; 40(1):91-100. PubMed ID: 20195659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of a peptidic antagonist of Id1 studied by biosensor method, circular dichroism spectroscopy, and bioassay.
    Yang SY; Chen Y; Yang CX; Yang DL; Kuo SC; Huang LJ; Lung FD
    J Pept Sci; 2011 Oct; 17(10):667-74. PubMed ID: 21805537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoscale tools to selectively destroy cancer cells.
    Boudreault PL; Arseneault M; Otis F; Voyer N
    Chem Commun (Camb); 2008 May; (18):2118-20. PubMed ID: 18438487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer Activities of Natural and Synthetic Peptides.
    Hilchie AL; Hoskin DW; Power Coombs MR
    Adv Exp Med Biol; 2019; 1117():131-147. PubMed ID: 30980357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designed antimicrobial and antitumor peptides with high selectivity.
    Hu J; Chen C; Zhang S; Zhao X; Xu H; Zhao X; Lu JR
    Biomacromolecules; 2011 Nov; 12(11):3839-43. PubMed ID: 21955251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and function of a custom anticancer peptide, CB1a.
    Wu JM; Jan PS; Yu HC; Haung HY; Fang HJ; Chang YI; Cheng JW; Chen HM
    Peptides; 2009 May; 30(5):839-48. PubMed ID: 19428759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
    Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
    Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
    Gaspar D; Freire JM; Pacheco TR; Barata JT; Castanho MA
    Biochim Biophys Acta; 2015 Feb; 1853(2):308-16. PubMed ID: 25447543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
    Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides.
    Schaduangrat N; Nantasenamat C; Prachayasittikul V; Shoombuatong W
    Molecules; 2019 May; 24(10):. PubMed ID: 31121946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toggling Preassembly with Single-Site Mutation Switches the Cytotoxic Mechanism of Cationic Amphipathic Peptides.
    Chen X; Ji S; Li A; Liu H; Fei H
    J Med Chem; 2020 Feb; 63(3):1132-1141. PubMed ID: 31927997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.